반응식
[CH3:1]C1C=CC=C2C=1C(=O)N(C1C=CC=CC=1)C(C(NC1N=CN=C3C=1N=CN3)CC)=N2.O=C1CCC(=O)N1OC(=O)C(NC([O:51][CH2:52][C:53]1[CH:58]=[CH:57][CH:56]=[CH:55][CH:54]=1)=O)COC(C)(C)C.O=C1CCC(=O)N1OC(=O)C(NC(OCC1C=CC=CC=1)=O)CC.NC1N=C2C(NC=N2)=C(Br)N=1.BrC1N=CN=C2C=1NC=N2.[NH2:105][C:106]1[N:114]=[C:113]2[C:109]([N:110]=[CH:111][NH:112]2)=[C:108]([NH:115][CH:116]([C:123]2[N:132](C3C=CC=CC=3)C(=O)[C:130]3[C:125](=[CH:126][CH:127]=[CH:128][C:129]=3C)[N:124]=2)[CH2:117][O:118]C(C)(C)C)[N:107]=1>FC(F)(F)C(O)=O>[NH2:105][C:106]1[N:114]=[C:113]2[C:109]([N:110]=[CH:111][NH:112]2)=[C:108]([NH:115][CH:116]([C:123]2[N:124]([C:125]3[CH:130]=[CH:129][CH:128]=[CH:127][CH:126]=3)[C:52](=[O:51])[C:53]3[C:54](=[CH:55][CH:56]=[CH:57][C:58]=3[CH3:1])[N:132]=2)[CH2:117][OH:118])[N:107]=1참가 물질
8
반응물 6
생성물 1
시약·촉매·용매 1
실험 절차
Compound 68 was prepared using the general procedure described above with respect to compound 14, but 2-benzyloxycarbonylamino-3-tert-butoxy-propionic acid 2,5-dioxo-pyrrolidin-1-yl ester was substituted for 2-benzyloxycarbonylaminobutyric acid 2,5-dioxo-pyrrolidin-1-yl ester in step B, and 2-amino-6-bromopurine was substituted for 6-bromopurine in step D. The obtained 2-[1-(2-amino-9H-purin-6-ylamino)-2-tert-butoxy-ethyl]-5-methyl-3-phenyl-3H-quinazolin-4-one was then dissolved in trifluoroacetic acid and allowed to stir at ambient temperature for 5 hours. Purification by LC provided the product 68 as a white solid. MS (ES): m/z 429 (M+H), 215, 206, 151. Compound 68 is shown below.
후처리
- customCompound 68 was prepared
- customPurification by LC
출처 및 근거
- ORD 기록
- ord-0cd03cdbc17f480da66b62c1e16b9c0a
- 출처 데이터셋
- uspto-grants-2015_10
- 특허 번호
- US09149477B2
연결된 노트
불러오는 중…